Eble JN, Sauter G., Epstein JI, Sesterhenn IA - iarc
Eble JN, Sauter G., Epstein JI, Sesterhenn IA - iarc
Eble JN, Sauter G., Epstein JI, Sesterhenn IA - iarc
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
A<br />
B<br />
Fig. 3.32 A Sarcomatoid carcinoma. Note both epithelial (upper centre) and mesenchymal differentiation. B High-magnification view of spindle cell component of<br />
sarcomatoid carcinoma of prostate.<br />
A<br />
B<br />
Fig. 3.33 A Cancer with radiation effect. The degenerating tumour cells are ballooned. Note pleomorphic hyperchromatic nuclei. B Adenocarcinoma with cancer<br />
showing radiation effect adjacent to cancer without evidence of radiation effect.<br />
Immunohistochemistry for PSA or pancytokeratin<br />
can aid in the diagnosis of carcinoma<br />
in these cases by identifying the<br />
individual cells as epithelial cells of prostatic<br />
origin. Cancer cells following hormonal<br />
therapy demonstrate a lack of high molecular<br />
weight cytokeratin staining, identical<br />
to untreated prostate cancer. Following a<br />
response to combination endocrine therapy,<br />
the grade of the tumour appears artefactually<br />
higher, when compared to the<br />
grade of the pretreated tumour. As with<br />
radiation, the response to hormonal therapy<br />
may be variable, with areas of the cancer<br />
appearing unaffected {117,340,470,<br />
1059,1852,2176,2447,2681}.<br />
Gleason grading system<br />
Numerous grading systems have been<br />
designed for histopathological grading<br />
of prostate cancer. The main controversies<br />
have been whether grading should<br />
be based on glandular differentiation<br />
alone or a combination of glandular differentiation<br />
and nuclear atypia, and also<br />
whether prostate cancer should be graded<br />
according to its least differentiated or<br />
dominant pattern. The Gleason grading<br />
system named after Donald F. Gleason is<br />
now the predominant grading system,<br />
and in 1993, it was recommended by a<br />
WHO consensus conference {1840}. The<br />
Gleason grading system is based on<br />
glandular architecture; nuclear atypia is<br />
not evaluated {894,895}. Nuclear atypia<br />
as adopted in some grading systems,<br />
correlates with prognosis of prostate<br />
cancer but there is no convincing evidence<br />
that it adds independent prognostic<br />
information to that obtained by grading<br />
glandular differentiation alone {1801}.<br />
The Gleason grading system defines five<br />
histological patterns or grades with<br />
decreasing differentiation. Normal<br />
prostate epithelial cells are arranged<br />
around a lumen. In patterns 1 to 3, there<br />
is retained epithelial polarity with luminal<br />
differentiation in virtually all glands. In<br />
pattern 4, there is partial loss of normal<br />
polarity and in pattern 5, there is an<br />
almost total loss of polarity with only<br />
occasional luminal differentiation.<br />
Prostate cancer has a pronounced morphological<br />
heterogeneity and usually<br />
more than one histological pattern is<br />
present. The primary and secondary pattern,<br />
i.e. the most prevalent and the second<br />
most prevalent pattern are added to<br />
obtain a Gleason score or sum. It is recommended<br />
that the primary and secondary<br />
pattern as well as the score be<br />
reported, e.g. Gleason score 3+4=7. If<br />
the tumour only has one pattern, Gleason<br />
score is obtained by doubling that pattern,<br />
e.g. Gleason score 3+3=6. Gleason<br />
scores 2 and 3 are only exceptionally<br />
Acinar adenocarcinoma<br />
179